Fresenius Kabi Deutschland Gmbh
SpainAll drugs from this manufacturer
-
It is used to provide nutrition through the bloodstream when a person cannot eat normally, supplying the amino acids necessary to build and repair muscles, organs, and other body structures.
Dosage form: solution for infusion
Active substance Dosage phenylalanine 5,1 g tryptophan 2,2 g glycine 11 g histidine 30 g isoleucine 5 g leucine 7,4 g threonine 4,4 g methionine 4,3 g proline 11,2 g lysine acetate 9,31 g valine 6,2 g alanine 14 g tyrosine 0,4 g arginine 12 g taurine 1 g serina 6,5 g -
It is used to provide nutrition through the bloodstream when it is not possible to eat normally. It provides amino acids that the body uses to manufacture proteins and repair muscles, organs, and other structures.
Dosage form: solution for infusion
Active substance Dosage phenylalanine 5,5 g tryptophan 1,6 g glycine 18,5 g histidine 7,3 g isoleucine 5,2 g leucine 8,9 g threonine 8,6 g methionine 3,8 g proline 17 g lysine acetate 15,66 g valine 5,5 g alanine 25 g tyrosine 0,4 g arginine 20 g taurine 2 g serina 9,6 g -
It is used in adults to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Dosage form: solution for injection
Active substance Dosage denosumab 70 mg/ml -
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Dosage form: solution for injection
Active substance Dosage denosumab 70 mg/ml -
It is used to treat multiple myeloma (a type of bone marrow cancer) in adults, either alone or in combination with other medicines, and also to treat mantle cell lymphoma (a type of lymph node cancer) in combination with other drugs.
Dosage form: powder for solution for injection
Active substance Dosage bortezomib 3,5 mg -
It is used in adults, newborns, children, and adolescents as conditioning treatment to prepare them before receiving a bone marrow or hematopoietic stem cell transplant.
Dosage form: solution for infusion, concentrate
Active substance Dosage busulfan 60 mg -
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture, as well as bone loss caused by testosterone reduction in patients with prostate cancer or by long-term use of glucocorticoids.
Dosage form: solution for injection
Active substance Dosage denosumab 60 mg/ml -
It is used as part of a clinical nutrition regimen in patients in hypercatabolic and hypermetabolic states. It must be administered alongside parenteral nutrition, enteral nutrition, or a combination of both.
Dosage form: solution for infusion, concentrate
Active substance Dosage l-alanyl-l-glutamine 20 g -
It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, ankylosing spondylitis, non-infectious uveitis, and other inflammatory conditions of the joints or skin.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage adalimumab 40.0 mg -
It is used to treat various inflammatory diseases such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-associated arthritis, ankylosing spondylitis, axial spondyloarthritis, psoriatic arthritis, psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, and non-infectious uveitis.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage adalimumab 40.0 mg -
It is used to provide amino acids as part of parenteral nutrition in patients with renal failure (acute or chronic), including those receiving dialysis treatment, when other types of feeding are not suitable.
Dosage form: solution for infusion
Active substance Dosage isoleucine 5,80 g leucine 12,8 g methionine 2,00 g acetylcysteine 0,54 g phenylalanine 3,50 g threonine 8,20 g tryptophan 3,00 g valine 8,70 g arginine 8,20 g histidine 9,80 g glycine 5,31 g alanine 6,20 g proline 3,00 g serina 7,60 g tyrosine 0,60 g lysine acetate 16,9 g -
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 130 mg -
It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection
Active substance Dosage ustekinumab 45 mg/ml -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg -
It is used for the treatment of cancer, specifically for malignant pleural mesothelioma (a type of cancer in the lung lining) and for advanced-stage lung cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage pemetrexed 25 mg -
It is used to induce and maintain general anesthesia in adults, adolescents, and children over 1 month of age. It is also used for sedation during surgical or diagnostic procedures and for the sedation of patients over 16 years of age in intensive care units.
Dosage form: solution for injection and infusion
Active substance Dosage propofol 10 mg -
It is used to induce unconsciousness (sleep) during surgical operations or medical procedures, and also to sedate patients (make them feel drowsy).
Dosage form: solution for injection and infusion
Active substance Dosage propofol 20,0 mg -
It is used to accelerate muscle recovery after surgery, allowing the person to return to breathing on their own more quickly after having received muscle relaxants during general anesthesia.
Dosage form: solution for injection
Active substance Dosage sugammadex sodium 108,8 mg -
It is used to treat active rheumatoid arthritis in adults (moderate to severe or severe and progressive), giant cell arteritis in adults, and systemic or polyarticular juvenile idiopathic arthritis in children and adolescents aged 12 years or older.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage tocilizumab 162 mg -
It is used to treat rheumatoid arthritis (RA) in adults, giant cell arteritis (GCA) in adults, and systemic juvenile idiopathic arthritis (sJIA) or polyarticular juvenile idiopathic arthritis (pJIA) in children and adolescents.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage tocilizumab 162 mg -
It is used to treat adults with moderate to severe active rheumatoid arthritis, adults with COVID-19 who require oxygen or mechanical ventilation, and individuals (adults and children aged 2 years and older) with severe or potentially life-threatening cytokine release syndrome. It is also used in children aged 2 years and older with systemic juvenile idiopathic arthritis (sJIA) or polyarticular juvenile idiopathic arthritis (pJIA).
Dosage form: solution for infusion, concentrate
Active substance Dosage tocilizumab 20 mg